EGFR and systemic sclerosis: In patients with SSc, new antibody correlations appeared between abs targeting AT1R, epidermal growth factor receptor (EGFR), and vascular endothelial growth receptors (VEGF-R1 and VEGF-R2) in comparison to heathy donors.